Marie‐Agnès Bernard
About
In The Last Decade
Marie‐Agnès Bernard
15 papers receiving 644 citations
Peers
Comparison fields: 5 of 62
- Hematology 416
- Genetics 339
- Rheumatology 202
- Molecular Biology 111
- Oncology 93
Countries citing papers authored by Marie‐Agnès Bernard
This map shows the geographic impact of Marie‐Agnès Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie‐Agnès Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie‐Agnès Bernard more than expected).
Fields of papers citing papers by Marie‐Agnès Bernard
This network shows the impact of papers produced by Marie‐Agnès Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie‐Agnès Bernard. The network helps show where Marie‐Agnès Bernard may publish in the future.
Co-authorship network of co-authors of Marie‐Agnès Bernard
This figure shows the co-authorship network connecting the top 25 collaborators of Marie‐Agnès Bernard. A scholar is included among the top collaborators of Marie‐Agnès Bernard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie‐Agnès Bernard. Marie‐Agnès Bernard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 | |
| 3 | 7 | |
| 4 | 5 | |
| 5 | 18 | |
| 6 | 18 | |
| 7 | Abstract 14523: Two-Year Benefit-Risk of Standard and Reduced Doses of Rivaroxaban versus Vitamin-K Antagonists in Non-Valvular Atrial Fibrillation: A Cohort Study in the French Nationwide Claims Database | 1 |
| 8 | 0 | |
| 9 | Abstract 20559: Effectiveness and Safety of Rivaroxaban 15 mg Compared With Vitamin K Antagonists in Very Elderly Patients With Atrial Fibrillation, a Matched Cohort Study in the French Nationwide Claims Database SNIIRAM | 1 |
| 10 | 19 | |
| 11 | 14 | |
| 12 | 1 | |
| 13 | 70 | |
| 14 | 17 | |
| 15 | 10 | |
| 16 | 468 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.